Ontology highlight
ABSTRACT:
SUBMITTER: Tuohy E
PROVIDER: S-EPMC3262353 | biostudies-other | 2011
REPOSITORIES: biostudies-other
Tuohy Emma E Litt Emma E Alikhan Raza R
Journal of blood medicine 20110420
Von Willebrand disease (vWD) is the most common hereditary bleeding disorder. The aim of therapy is to correct the dual hemostatic defect, due to defective platelet adhesion-aggregation and abnormal coagulation due to Factor VIII (FVIII) deficiency. The choice of treatment depends on a number of factors, including the severity of the bleed, the procedure planned, the subtype and severity of the disease and the age and morbidity of the patient. Desmopressin (DDAVP) is the treatment of choice for ...[more]